2018
Overview
Artesunate is a medication that has been studied extensively in the fields of hematology and oncology research. It belongs to the artemisinin family of drugs and has shown promise in the treatment of various types of cancer. Studies have shown that artesunate can induce cancer cell death, known as apoptosis, and inhibit the growth and spread of cancer cells. Artensunate has also been found to enhance the effectiveness of traditional chemotherapy and reduce its toxic side effects. In the field of hematology, artesunate has been studied for its potential use in the treatment of sickle cell disease. It has been shown to improve red blood cell deformability, reduce inflammation, and reduce the frequency of sickle cell crisis. Additionally, artesunate has been found to have anti-inflammatory and anti-malarial properties. It has been used in the treatment of severe malaria and has been found to be effective in reducing mortality rates in areas where malaria is endemic. Overall, the research on artesunate in the fields of hematology and oncology continues to be promising. Further studies are needed to fully understand its potential uses and effectiveness in treating these specific diseases, but the current literature suggests that artesunate may be a valuable addition to existing treatment options.
Research published in this journal
2 peer-reviewed articles, ranked by relevance. Each links to its DOI.
2019
How this research is being cited
The 2 articles above have been cited 3 times in the scholarly literature. Citation data via OpenAlex and Crossref, updated Oct 2025.
-
Jaekwon Seok et al. · 2023 · Journal of Translational Medicine
-
Iman Ehsan et al. · 2022 · Journal of Drug Delivery Science and Technology
-
2019 · Journal of Experimental and Clinical Toxicology
A sample of recent works citing this journal's research on Artesunate, linking to each citing work.